{ "id": "eprt53tcxb", "slug": "cytodiagnosis", "title": "Cytodiagnosis", "updated": "2026-10-25", "topic_path": [ { "id": "life", "label": "Life and health", "api_url": "https://www.edgepedia.org/api/v1/topics/life" }, { "id": "life.health", "label": "Human health and medicine", "api_url": "https://www.edgepedia.org/api/v1/topics/life.health" }, { "id": "life.health.clinical", "label": "Clinical assessment and procedures", "api_url": "https://www.edgepedia.org/api/v1/topics/life.health.clinical" }, { "id": "life.health.clinical.clinical-diagnostics", "label": "Diagnosis and clinical assessment", "api_url": "https://www.edgepedia.org/api/v1/topics/life.health.clinical.clinical-diagnostics" }, { "id": "life.health.clinical.clinical-diagnostics.laboratory-and-in-vitro-diagnostics", "label": "Laboratory and in-vitro diagnostics", "api_url": "https://www.edgepedia.org/api/v1/topics/life.health.clinical.clinical-diagnostics.laboratory-and-in-vitro-diagnostics" }, { "id": "life.health.clinical.clinical-diagnostics.laboratory-and-in-vitro-diagnostics.serology-and-immunoassays", "label": "Serology and immunoassays", "api_url": "https://www.edgepedia.org/api/v1/topics/life.health.clinical.clinical-diagnostics.laboratory-and-in-vitro-diagnostics.serology-and-immunoassays" } ], "geo": [ { "id": "geo.nongeo.t1800.life.health.clinical.clinical-diagnostics.laboratory-and-in-vitro-diagnostics", "label": "Non-geographic · 1800 to 1945: Laboratory and in-vitro diagnostics", "api_url": "https://www.edgepedia.org/api/v1/geo/geo.nongeo.t1800.life.health.clinical.clinical-diagnostics.laboratory-and-in-vitro-diagnostics", "path": [ { "id": "geo.nongeo", "label": "Non-geographic", "api_url": "https://www.edgepedia.org/api/v1/geo/geo.nongeo" }, { "id": "geo.nongeo.t1800", "label": "Non-geographic · 1800 to 1945", "api_url": "https://www.edgepedia.org/api/v1/geo/geo.nongeo.t1800" }, { "id": "geo.nongeo.t1800.life", "label": "Life and health", "api_url": "https://www.edgepedia.org/api/v1/geo/geo.nongeo.t1800.life" }, { "id": "geo.nongeo.t1800.life.health", "label": "Human health and medicine", "api_url": "https://www.edgepedia.org/api/v1/geo/geo.nongeo.t1800.life.health" }, { "id": "geo.nongeo.t1800.life.health.clinical", "label": "Clinical assessment and procedures", "api_url": "https://www.edgepedia.org/api/v1/geo/geo.nongeo.t1800.life.health.clinical" }, { "id": "geo.nongeo.t1800.life.health.clinical.clinical-diagnostics", "label": "Diagnosis and clinical assessment", "api_url": "https://www.edgepedia.org/api/v1/geo/geo.nongeo.t1800.life.health.clinical.clinical-diagnostics" }, { "id": "geo.nongeo.t1800.life.health.clinical.clinical-diagnostics.laboratory-and-in-vitro-diagnostics", "label": "Laboratory and in-vitro diagnostics", "api_url": "https://www.edgepedia.org/api/v1/geo/geo.nongeo.t1800.life.health.clinical.clinical-diagnostics.laboratory-and-in-vitro-diagnostics" } ] }, { "id": "geo.nongeo.t1946.life.health.clinical.clinical-diagnostics.laboratory-and-in-vitro-diagnostics", "label": "Non-geographic · 1946 to 2000: Laboratory and in-vitro diagnostics", "api_url": "https://www.edgepedia.org/api/v1/geo/geo.nongeo.t1946.life.health.clinical.clinical-diagnostics.laboratory-and-in-vitro-diagnostics", "path": [ { "id": "geo.nongeo", "label": "Non-geographic", "api_url": "https://www.edgepedia.org/api/v1/geo/geo.nongeo" }, { "id": "geo.nongeo.t1946", "label": "Non-geographic · 1946 to 2000", "api_url": "https://www.edgepedia.org/api/v1/geo/geo.nongeo.t1946" }, { "id": "geo.nongeo.t1946.life", "label": "Life and health", "api_url": "https://www.edgepedia.org/api/v1/geo/geo.nongeo.t1946.life" }, { "id": "geo.nongeo.t1946.life.health", "label": "Human health and medicine", "api_url": "https://www.edgepedia.org/api/v1/geo/geo.nongeo.t1946.life.health" }, { "id": "geo.nongeo.t1946.life.health.clinical", "label": "Clinical assessment and procedures", "api_url": "https://www.edgepedia.org/api/v1/geo/geo.nongeo.t1946.life.health.clinical" }, { "id": "geo.nongeo.t1946.life.health.clinical.clinical-diagnostics", "label": "Diagnosis and clinical assessment", "api_url": "https://www.edgepedia.org/api/v1/geo/geo.nongeo.t1946.life.health.clinical.clinical-diagnostics" }, { "id": "geo.nongeo.t1946.life.health.clinical.clinical-diagnostics.laboratory-and-in-vitro-diagnostics", "label": "Laboratory and in-vitro diagnostics", "api_url": "https://www.edgepedia.org/api/v1/geo/geo.nongeo.t1946.life.health.clinical.clinical-diagnostics.laboratory-and-in-vitro-diagnostics" } ] } ], "excerpt": "Cytodiagnosis is the diagnosis of disease by microscopic examination of individual cells, clusters, and tissue fragments from body fluids, scrapings, and fine-needle aspirates, usually confirmed by biopsy.", "snippet": "Cytodiagnosis is the diagnosis of disease by microscopic examination of individual cells, clusters, and tissue fragments from body fluids, scrapings, and fine-needle aspirates, usually confirmed by biopsy.", "node": "life.health.clinical.clinical-diagnostics.laboratory-and-in-vitro-diagnostics.serology-and-immunoassays", "markdown": "# Cytodiagnosis\n\nCytodiagnosis is the diagnosis of disease by microscopic examination of individual cells, cell clusters, and small tissue fragments obtained from body fluids, scrapings or brushings, and fine-needle aspirates. It is described as a cost-effective, simple, accurate, and safe way to reach a specific diagnosis that dictates management decisions, and it serves both screening and diagnostic purposes, with a biopsy usually confirming the diagnosis before treatment.[1](https://www.cancer.org/cancer/diagnosis-staging/tests/biopsy-and-cytology-tests/cytology-types.html) • [2](https://pmc.ncbi.nlm.nih.gov/articles/PMC3507055/)\n\n| Key fact | Detail |\n|---|---|\n| Specimen routes | Exfoliative and brush samples (Pap test, sputum, urine), body fluids (pleural, pericardial, ascitic, cerebrospinal), and fine-needle aspiration[1](https://www.cancer.org/cancer/diagnosis-staging/tests/biopsy-and-cytology-tests/cytology-types.html) |\n| Slide workload | A cytologist examines glass slides holding roughly 10,000 to 1,000,000 cells each[3](https://www.nature.com/articles/s41586-025-10094-y) |\n| Stains | Papanicolaou stain for nuclear detail; Diff-Quik (modified Romanowsky) for cytoplasm, background, and microorganisms; H&E for cell blocks[2](https://pmc.ncbi.nlm.nih.gov/articles/PMC3507055/) |\n| Thyroid FNA accuracy | Conventional smears: sensitivity 0.8266, specificity 0.8668; liquid-based preparations: 0.8190 and 0.8833, with no significant difference between the two[4](https://www.mdpi.com/2072-6694/16/4/751) |\n| Cervical screening accuracy (LMICs) | Conventional Pap smear: sensitivity 60.2%, specificity 97.4%; primary HPV testing: 79.5% and 72.6%[5](https://journals.plos.org/globalpublichealth/article/file?id=10.1371%2Fjournal.pgph.0001598&type=printable) |\n| Reporting systems | Bethesda (cervix, thyroid), Paris (urine), Milan (salivary gland), Papanicolaou Society (pancreatobiliary), BSP (breast)[6](https://pmc.ncbi.nlm.nih.gov/articles/PMC12283066/) • [7](https://www.rcpath.org/static/b328ab3d-f574-40f1-8717c32ccfc4f7d8/G086-Tissue-pathways-for-diagnostic-cytopathology.pdf) |\n| Main failure modes | Sampling error, desmoplasia, well-differentiated tumors, obscuring blood or inflammation, and observer dependence[2](https://pmc.ncbi.nlm.nih.gov/articles/PMC3507055/) • [8](https://link.springer.com/article/10.1186/s42047-026-00222-x) |\n\n## How it works\n\nIn routine practice a cytologist assesses individual cells and clusters under an optical microscope, judging three-dimensional nuclear and cytoplasmic morphology and the spatial relationships between neighboring cells.[3](https://www.nature.com/articles/s41586-025-10094-y) For fine-needle aspiration (FNA) material, interpretation involves assessment of cell morphology, cell-to-cell interaction, tissue fragment architecture (a micro-biopsy), and the extracellular matrix, integrated with clinical and imaging data.[9](http://www.papsociety.org/guidelines/FNAprocedure.pdf)\n\nThe interpretation may equal a specific histologic diagnosis (for example, squamous cell carcinoma), a differential diagnosis (for example, follicular thyroid neoplasm, adenoma versus carcinoma), a descriptive diagnosis, or the exclusion of a specific clinical diagnosis.[9](http://www.papsociety.org/guidelines/FNAprocedure.pdf) Cytology tests differ from biopsies because they use a few cells rather than a larger tissue sample; they cannot show how cells are arranged in tissue or how deeply a tumor has grown, yet they are often just as useful.[1](https://www.cancer.org/cancer/diagnosis-staging/tests/biopsy-and-cytology-tests/cytology-types.html)\n\n## How it is done\n\nCollection routes divide into exfoliative samples (cells shed naturally or by direct sampling), brush or scrape biopsies such as the [Pap test](https://www.edgepedia.org/pap-test), body fluids including ascitic, pericardial, and pleural fluid, cerebrospinal fluid, sputum, and urine, and FNA, in which a very thin hollow needle on a syringe aspirates fluid and small tissue pieces from areas such as lymph nodes, breast lumps, or thyroid nodules.[1](https://www.cancer.org/cancer/diagnosis-staging/tests/biopsy-and-cytology-tests/cytology-types.html) • [7](https://www.rcpath.org/static/b328ab3d-f574-40f1-8717c32ccfc4f7d8/G086-Tissue-pathways-for-diagnostic-cytopathology.pdf) The pre-analytical phase of collection, handling, triage, and processing is as important as the other phases; specimens may arrive as air-dried or fixed slides, aspirates, or saline or needle washes, and should ideally reach the laboratory within minutes.[7](https://www.rcpath.org/static/b328ab3d-f574-40f1-8717c32ccfc4f7d8/G086-Tissue-pathways-for-diagnostic-cytopathology.pdf)\n\nInitial FNA smears are usually stained with a quick stain such as Diff-Quik, a modified Romanowsky stain performed on air-dried slides, while other slides are fixed in 95% ethanol for the Papanicolaou stain; cell blocks are stained with hematoxylin and eosin.[2](https://pmc.ncbi.nlm.nih.gov/articles/PMC3507055/) Papanicolaou stain is superior for demonstrating the nuclear details most important in diagnosing malignancy, while Diff-Quik better shows microorganisms, cytoplasm, and background material, so a Papanicolaou-stained and a Romanowsky-stained slide are recommended for most samples; with liquid-based cytology a Papanicolaou slide is often adequate.[2](https://pmc.ncbi.nlm.nih.gov/articles/PMC3507055/) • [7](https://www.rcpath.org/static/b328ab3d-f574-40f1-8717c32ccfc4f7d8/G086-Tissue-pathways-for-diagnostic-cytopathology.pdf) For FNA, one or two passes per lesion with a pair of slides per pass is recommended, and residual needle material is rinsed into liquid medium for a cell block and ancillary studies.[7](https://www.rcpath.org/static/b328ab3d-f574-40f1-8717c32ccfc4f7d8/G086-Tissue-pathways-for-diagnostic-cytopathology.pdf)\n\n## Origin\n\nThe 1920s were formative years for diagnostic cytology: the first monograph of clinical cytology was published in Spain, and papers on detecting uterine cervical cancer by examining vaginal smears appeared.[10](https://www.annclinlabsci.org/content/38/3/296.short) Vaginal smears were described as having potential value in diagnosing cervical cancer, and a publication described a platinum-loop technique with air-drying, methyl-alcohol fixation, and [Giemsa stain](https://www.edgepedia.org/giemsa-stain).[11](https://www.auajournals.org/doi/10.1016/j.juro.2016.02.103) Findings of cancer cells in vaginal aspirates were presented at the Third Race Betterment Conference in [Battle Creek, Michigan](https://www.edgepedia.org/battle-creek-michigan); the article appeared only in the conference proceedings and remained obscure.[11](https://www.auajournals.org/doi/10.1016/j.juro.2016.02.103) The leading article, on the diagnosis of uterine cancer by the vaginal smear, appeared in the American Journal of Obstetrics and Gynecology, followed by a second article two years later.[11](https://www.auajournals.org/doi/10.1016/j.juro.2016.02.103) The medical profession largely ignored both discoveries for nearly two decades, while in the 1930s cytologic examination was extended to all body sites and specimens.[10](https://www.annclinlabsci.org/content/38/3/296.short) Papers describing tumor diagnosis by cytological examination were published from New York Memorial Hospital.[2](https://pmc.ncbi.nlm.nih.gov/articles/PMC3507055/)\n\nPriority remains disputed. One analysis argues that the Pap smear is the Babes-Papanicolaou Method.[11](https://www.auajournals.org/doi/10.1016/j.juro.2016.02.103) A 2010 counterpoint concludes that the establishment of the technique in clinical practice and the idea of its application as preventive control of cervical cancer belong solely to George Papanicolaou.[12](https://onlinelibrary.wiley.com/doi/10.1002/dc.21226) A 2023 survey in Sudhoffs Archiv re-examined the early publications of Babes (alone or with Daniel) and Papanicolaou against the background of 19th- and early 20th-century medical history.[13](https://biblioscout.net/en/article/10.25162/sar-2023-0004)\n\n## Variants\n\nAn early classification, the Papanicolaou Classification System, initially covered vaginal samples and was later expanded to cervical, urinary, sputum, and effusion samples.[6](https://pmc.ncbi.nlm.nih.gov/articles/PMC12283066/) Organ-specific systems now govern most reporting. The Bethesda System for Reporting Cervical Cytology published edition books in 1994, 2004, and 2015.[6](https://pmc.ncbi.nlm.nih.gov/articles/PMC12283066/) The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC), with editions in 2010, 2018, and 2023, includes six diagnostic categories, among them nondiagnostic, benign, atypia of undetermined significance/follicular lesion of undetermined significance (AUS/FLUS), and follicular neoplasm/suspicious for follicular neoplasm (FN/SFN).[6](https://pmc.ncbi.nlm.nih.gov/articles/PMC12283066/) • [14](https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncy.22228) A diagnostic thyroid sample is defined as containing at least six groups of 10 well-preserved and well-stained follicular cells, although exceptions exist, such as cases with abundant colloid or aspirates with abundant lymphocytic infiltration.[6](https://pmc.ncbi.nlm.nih.gov/articles/PMC12283066/) The Paris System for Reporting Urinary Cytology (2016, second edition 2022) covers voided and instrumented urine and focuses on high-grade urothelial carcinoma; when atypical, suspicious, or malignant cells are present, classification follows cytomorphology and adequacy criteria such as cellularity need not be fulfilled.[6](https://pmc.ncbi.nlm.nih.gov/articles/PMC12283066/) The Milan System for Reporting Salivary Gland Cytopathology (2018, second edition 2022) has documented validity, reliability, and reproducibility.[6](https://pmc.ncbi.nlm.nih.gov/articles/PMC12283066/) The Royal College of Pathologists also lists the Papanicolaou Society system for pancreatobiliary specimens and the BSP classification for breast FNA.[7](https://www.rcpath.org/static/b328ab3d-f574-40f1-8717c32ccfc4f7d8/G086-Tissue-pathways-for-diagnostic-cytopathology.pdf)\n\n[Liquid-based cytology](https://www.edgepedia.org/liquid-based-cytology) suspends collected cells in a liquid fixating medium before processing, enables computer-assisted screening and adjunct HPV DNA testing, and is now the standard method for preparing Papanicolaou smears.[2](https://pmc.ncbi.nlm.nih.gov/articles/PMC3507055/) • [15](https://karger.com/acy/article/doi/10.1159/000551747/949123/Liquid-Based-Cytology-in-Cervical-Cancer-Screening) Bethesda adequacy criteria require approximately 8,000–12,000 well-preserved squamous epithelial cells for satisfactory conventional smears and a 5,000-cell threshold for liquid-based preparations.[6](https://pmc.ncbi.nlm.nih.gov/articles/PMC12283066/)\n\n## Applications\n\nA meta-analysis of 17 studies comprising 15,861 thyroid FNA samples found no significant difference in diagnostic accuracy or inadequacy rates between conventional smears and liquid-based preparations, with sensitivities of 0.8266 and 0.8190 and specificities of 0.8668 and 0.8833, respectively.[4](https://www.mdpi.com/2072-6694/16/4/751) In cervical screening across 97 studies, liquid-based cytology had a lower unsatisfactory sample rate than conventional cytology (RR 0.63, 95% CI 0.47–0.85), a 35% higher histology-confirmed abnormal detection rate (RR 1.35), and a 27% higher detection of confirmed CIN2+ lesions (RR 1.27); squamous cell carcinoma and glandular abnormality detection showed no overall difference.[15](https://karger.com/acy/article/doi/10.1159/000551747/949123/Liquid-Based-Cytology-in-Cervical-Cancer-Screening) In low- and middle-income countries, pooled sensitivity for conventional Pap smear was 60.2% with 97.4% specificity, compared with 79.5% sensitivity and 72.6% specificity for primary [HPV testing](https://www.edgepedia.org/hpv-testing).[5](https://journals.plos.org/globalpublichealth/article/file?id=10.1371%2Fjournal.pgph.0001598&type=printable) For lung cancer, conventional cytopathology sensitivity ranges from 0.49 to 0.71 for exfoliative sputum cytology and from 0.43 to 0.59 for abrasive bronchoscopic cytology.[16](https://link.springer.com/article/10.1186/s40001-024-02138-2)\n\nA 2024 review found that AI-assisted machine learning and deep learning applied to cervical, bone marrow, blood smear, and lung cytopathological data yielded greater diagnostic accuracy, specificity, and sensitivity, and decreased interobserver variability.[16](https://link.springer.com/article/10.1186/s40001-024-02138-2) Hologic markets Genius Cervical AI as the first CE-marked digital cytology platform combining an AI algorithm with volumetric imaging technology to help identify pre-cancerous lesions and cancer cells.[17](https://www.hologic.com/en/hologic-products/cytology/genius-cervical-ai) Whole-slide edge tomography achieved clinical-grade autonomous cytopathology in research published in Nature in 2025.[3](https://www.nature.com/articles/s41586-025-10094-y) An AI-assisted compact-microscope approach for cervical precancerous screening is used in resource-limited regions; low- and middle-income countries such as South Africa, India, China, and Brazil account for 84% to 90% of cervical cancer cases.[18](https://www.nature.com/articles/s41467-025-62589-x) Gynecological cytology has also moved from the conventional smear through liquid-based cytology and automation toward HPV vaccination, HPV primary screening, and personalized screening using HPV testing and [dual staining](https://www.edgepedia.org/dual-staining).[19](https://karger.com/acy/article/doi/10.1159/000552509/951643/The-Development-Path-of-Gynecological-Cytology)\n\n## Limitations and alternatives\n\nBoth false-negative and false-positive diagnoses can still occur despite efforts at accuracy.[2](https://pmc.ncbi.nlm.nih.gov/articles/PMC3507055/) False negatives are most commonly related to sampling problems, such as the needle not being in the appropriate lesion of interest.[2](https://pmc.ncbi.nlm.nih.gov/articles/PMC3507055/) Desmoplasia, the tumor-induced fibrosis most notorious in mammary, pancreatic, and biliary tree carcinomas and nodular sclerosing [Hodgkin lymphoma](https://www.edgepedia.org/hodgkin-lymphoma), can cause false-negative FNA; applying negative pressure and taking multiple passes can help.[2](https://pmc.ncbi.nlm.nih.gov/articles/PMC3507055/) Well-differentiated tumors such as thyroid follicular carcinoma and hepatocellular carcinoma can be deceiving on cytology, and final diagnosis on tissue sections may be more appropriate.[2](https://pmc.ncbi.nlm.nih.gov/articles/PMC3507055/) In cervical samples, excess blood, mucus, lubricant, and inflammation can obscure diagnostic cells and make specimens unsatisfactory even with adequate cellularity.[6](https://pmc.ncbi.nlm.nih.gov/articles/PMC12283066/) Cytopathology is also an observer-dependent method subject to inter- and intra-observer variability, professional experience, work overload, and technical factors of collection, fixation, and slide preparation.[8](https://link.springer.com/article/10.1186/s42047-026-00222-x)\n\nFNA has been reported in the literature to be unreliable in distinguishing lobular from ductal carcinomas and in assessing tumor grade and Her-2-neu status compared with core needle biopsy.[20](https://www.sciencedirect.com/science/article/abs/pii/S0272271205000776) For the thyroid AUS/FLUS category, the recommended risk of malignancy is 13.0% to 15.7%; if atypia is attributable to technical issues, repeat FNA cytology is warranted, and if smear quality is adequate but atypia persists, repeat FNA or core-needle biopsy is recommended.[21](https://synapse.koreamed.org/articles/1516089669)\n\n## References\n\n1. [How Is a Cytology Test Done? (American Cancer Society)](https://www.cancer.org/cancer/diagnosis-staging/tests/biopsy-and-cytology-tests/cytology-types.html)\n2. [Basics of cytology (CytoJournal / PMC)](https://pmc.ncbi.nlm.nih.gov/articles/PMC3507055/)\n3. [Clinical-grade autonomous cytopathology through whole-slide edge tomography](https://www.nature.com/articles/s41586-025-10094-y)\n4. [Comparison of Liquid-Based Preparations with Conventional Smears in Thyroid Fine-Needle Aspirates: A Systematic Review and Meta-Analysis](https://www.mdpi.com/2072-6694/16/4/751)\n5. [Performance of screening tools for cervical neoplasia among women in low- and middle-income countries: A systematic review and meta-analysis](https://journals.plos.org/globalpublichealth/article/file?id=10.1371%2Fjournal.pgph.0001598&type=printable)\n6. [Not Enough Cells: How Insufficient Cytological Specimens Are Mirrored by Reporting Systems – Journey from the Bethesda to the WHO Reporting Systems](https://pmc.ncbi.nlm.nih.gov/articles/PMC12283066/)\n7. [Tissue pathways for diagnostic cytopathology (Royal College of Pathologists, G086)](https://www.rcpath.org/static/b328ab3d-f574-40f1-8717c32ccfc4f7d8/G086-Tissue-pathways-for-diagnostic-cytopathology.pdf)\n8. [Artificial intelligence use in the routine of cervical-vaginal cytology: a systematic review](https://link.springer.com/article/10.1186/s42047-026-00222-x)\n9. [Guidelines of the Papanicolaou Society of Cytopathology for fine-needle aspiration procedure and reporting](http://www.papsociety.org/guidelines/FNAprocedure.pdf)\n10. [Foundation of Diagnostic Cytology (Annals of Clinical and Laboratory Science)](https://www.annclinlabsci.org/content/38/3/296.short)\n11. [NOT YOUR PAPPY'S TEST: THE ORIGINS OF THE 'PAP' SMEAR (Journal of Urology abstract)](https://www.auajournals.org/doi/10.1016/j.juro.2016.02.103)\n12. [What's in a name? Evidence that Papanicolaou, not Babes, deserves credit for the PAP test (Diagnostic Cytopathology, 2010)](https://onlinelibrary.wiley.com/doi/10.1002/dc.21226)\n13. [Was the Cytologic Method for Cervical Cancer Diagnosis discovered by Serendipity or by Design (Sudhoffs Archiv, 2023)](https://biblioscout.net/en/article/10.25162/sar-2023-0004)\n14. [Differences in surgical resection rate and risk of malignancy in thyroid cytopathology practice between Western and Asian countries: A systematic review and meta-analysis](https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncy.22228)\n15. [Liquid-Based Cytology in Cervical Cancer Screening: A Systematic Review and Meta-Analysis](https://karger.com/acy/article/doi/10.1159/000551747/949123/Liquid-Based-Cytology-in-Cervical-Cancer-Screening)\n16. [Artificial intelligence in cytopathological applications for cancer: a review of accuracy and analytic validity](https://link.springer.com/article/10.1186/s40001-024-02138-2)\n17. [Genius Cervical AI (Hologic product page)](https://www.hologic.com/en/hologic-products/cytology/genius-cervical-ai)\n18. [AI-assisted cervical cytology precancerous screening for high-risk population in resource-limited regions using a compact microscope](https://www.nature.com/articles/s41467-025-62589-x)\n19. [The Development Path of Gynecological Cytology after Papanicolaou: From Bethesda to Artificial Intelligence and Personalized Medicine](https://karger.com/acy/article/doi/10.1159/000552509/951643/The-Development-Path-of-Gynecological-Cytology)\n20. [Core Needle Biopsy Versus Fine Needle Aspiration Biopsy: Are There Similar Sampling and Diagnostic Issues?](https://www.sciencedirect.com/science/article/abs/pii/S0272271205000776)\n21. [KoreaMed Synapse (thyroid FNA management commentary)](https://synapse.koreamed.org/articles/1516089669)\n\n---\n*Topic: Encyclopedia › Life and health › Human health and medicine › Clinical assessment and procedures › Diagnosis and clinical assessment › Laboratory and in-vitro diagnostics › Serology and immunoassays*\n\n*Initially written Sep 29, 2026 · Edited: Oct 15, 2026; Oct 25, 2026*\n\n*Copyright 2026 EdgeChat AI, a subsidiary of Biostate AI.*\n\nLicense: Edgepedia Community License 1.0, https://www.edgepedia.org/edgepedia/license\n", "same_as": [], "url": "https://www.edgepedia.org/cytodiagnosis", "markdown_url": "https://www.edgepedia.org/cytodiagnosis.md", "license": { "name": "Edgepedia Community License 1.0", "url": "https://www.edgepedia.org/edgepedia/license", "summary": "Free with credit, commercial use included. AI training is open to everyone. For other uses, organizations over USD 100M in revenue or 100M monthly users license separately.", "spdx": "LicenseRef-Edgepedia-Community-1.0" }, "credit": "\"Cytodiagnosis\", Edgepedia (EdgeChat), https://www.edgepedia.org/cytodiagnosis. Edgepedia Community License 1.0.", "credit_md": "\"[Cytodiagnosis](https://www.edgepedia.org/cytodiagnosis)\", Edgepedia (EdgeChat), [https://www.edgepedia.org/cytodiagnosis](https://www.edgepedia.org/cytodiagnosis). [Edgepedia Community License 1.0](https://www.edgepedia.org/edgepedia/license).", "credit_html": "\"Cytodiagnosis\", Edgepedia (EdgeChat), https://www.edgepedia.org/cytodiagnosis. Edgepedia Community License 1.0.", "speakable": "Cytodiagnosis is the diagnosis of disease by microscopic examination of individual cells, clusters, and tissue fragments from body fluids, scrapings, and fine-needle aspirates, usually confirmed by biopsy." }